Jeil Pharm Cash Flow Quality Index
Jeil Pharm cash flow quality index. Jeil Pharm (002620) has a Cash Flow Quality Index of 0.41x as of March 2026. Operating cash flow of ₩447.08 Million is below net income of ₩1.10 Billion, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Jeil Pharm to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jeil Pharm (2011–2025)
Cash flow quality index of Jeil Pharm from 2011 to 2025. Historical Cash Flow Quality Index for Jeil Pharm across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 002620 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Jeil Pharm Cash Flow Quality Index by Year (2011–2025)
Jeil Pharm cash flow quality index by year from 2011 to 2025. Year-by-year earnings quality comparison for Jeil Pharm. For the full cash flow conversion analysis, see Jeil Pharm (002620) cash flow conversion.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | ₩390.26 Million | ₩14.64 Billion | ▲ +101.3% |
| 2020 | -2.07x | ₩-23.67 Billion | ₩11.43 Billion | ▼ -326.5% |
| 2018 | -0.49x | ₩-3.43 Billion | ₩7.07 Billion | ▼ -4365.5% |
| 2017 | 0.01x | ₩5.92 Billion | ₩520.35 Billion | ▼ -99.2% |
| 2016 | 1.44x | ₩11.36 Billion | ₩7.89 Billion | ▲ +412.1% |
| 2015 | 0.28x | ₩2.74 Billion | ₩9.76 Billion | ▲ +179.6% |
| 2012 | -0.35x | ₩-3.94 Billion | ₩11.17 Billion | ▼ -140.4% |
| 2011 | 0.87x | ₩23.63 Billion | ₩27.01 Billion | — |